TiHawk9 has a nonporous layer of titanium at the device’s bony interface and is used for minimally invasive spine surgery. It’s the latest addition to Accelus’ FlareHawk family of spinal fusion cages.
“We are thrilled with the final TiHawk device, as it features a layer of titanium that still allows for a surgeon to assess fusion radiographically in the office, as well as the same minimal insertion profile, multidirectional expansion and maximum bone graft delivery that surgeons have come to expect from FlareHawk interbody devices,” CEO Chris Walsh said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
